View Featured Offers >>

TMT10plex™ Total Proteome Profiling

TMT10plex™ Total Proteome profiling service provides accurate global profiling of protein abundance in cells and tissues, using multiplexed sample labeling with Tandem Mass Tags™ (TMT™) and liquid chromatography tandem mass spectrometry (LC-MS/MS). Together, these technologies enable proteomics-driven discovery, biomarker analysis, and mechanism-of-action studies to be carried out with greater depth of coverage while delivering high quality, quantitative data on thousands of proteins with predictable and reliable turnaround times.


TMT10plex™ Total Proteome services are performed on a Thermo Scientific™ Orbitrap Fusion™ Lumos™ Tribrid™ mass spectrometer, which provides the highest number of protein identifications and the most accurate quantitation compared to other instrumentation. CST is one of the first licensed commercial providers of TMT10plex™ proteomic services in the U.S.

Sample Prep

Sample preparation is easy. Just send frozen cell or tissue samples (just 100 μg total protein per sample) and our team will do the rest. Total Proteome services are available by assay runs of 10 samples; for projects involving >10 samples, one of the channels is reserved for a control peptide mix.

Multiplexing with TMT™

TMT™ labels are isobaric mass tags that use amine-reactive chemistry to label all peptides present in a digested sample. Thousands of proteins may be routinely detected and quantified in each study. Samples (100 μg input protein each) are uniquely labeled, combined into a single sample, fractionated, and run in LC-MS/MS, offering significant flexibility for experimental design. Studies greater than 10 samples can be analyzed using a control reference mixture in each TMT10plex™ assay, allowing projects of any size to be run.

Experimental design approaches may include:

  • Tumor profiling
  • Compound library screening
  • Dose dependence studies
  • Time-course studies
  • Cell line, primary cell type, or tissue type comparison
  • Ligand, agonist, and/or antagonist analyses

What You Get

CST’s proteomics scientists’ partner with our clients to provide defined timelines and consultative support throughout the project, from pre-study planning to data analysis and follow-up. Clients receive a comprehensive data package including:

  • Results table and slide deck containing protein identifications and TMT™ quantitation.
  • Post-study consultation.
  • Optional mapping of TMT10plex™ Total Proteome results to canonical pathways and new interaction networks using Qiagen’s Ingenuity® Pathway Analysis (IPA) software (available as an additional service).

View TMT10plex™ Total Proteome Analysis results across 14 human cell lines.

Contact us for further information on TMT10plex™ Proteomic Services.

Note: TMT10plex™ Total Proteome service is available for US, UK and Europe-based customers only.

Cell Signaling Technology and CST are trademarks of Cell Signaling Technology, Inc.

Thermo, Thermo Fisher, Thermo Fisher Scientific, TMT10plex, Fusion, Lumos, and Tribrid are licensed trademarks of Thermo Fisher Scientific and its subsidiaries.

Tandem Mass Tag, TMT, and TMT10plex are licensed trademarks of Electrophoretics Limited.

Ingenuity is a licensed trademark of Qiagen.

These proteomic services and resulting deliverables are sold under an agreement for Tandem Mass Tag™ (TMT™) technology between Pierce Biotechnology, Inc and Cell Signaling Technology, Inc. and are provided for internal research puposes only. No rights for clinical activities or studies or for any Commercial Purpose are conveyed hereunder. In no event will the producer or distributor of TMT™ technology be liable for incidental, special, multiple or consequential damages in connection with or arising from the use of these services or deliverables.

“Commercial Purposes” means any (i) use for the analysis of nucleic acids for genomic purposes; (ii) use, directly or indirectly, in manufacturing, production, or quality control; (iii) use to provide a service, information, or data for consideration; (iv) use for therapeutic, diagnostic or prophylactic purposes; or (v) sale, resale, leasing, or licensing, whether or not for research purposes. For purposes of clarification, Commercial Purpose does not include use to provide information or data to an end-user’s subcontractors or its contract research organizations that are conducting research on behalf of said end-user.

For information on acquiring rights for any use not permitted herein, please contact Pierce Biotechnology outlicensing at [email protected].